FY2025 · period end Dec '25 · from the 10-K filed Feb 4, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $38.54B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001628280-26-044384 | Jun 15, 2026 | Jun 18, 2026 | Jun 18, 2026 20:45 UTC | EDGAR |
| 8-K | 0001628280-26-038064 | May 20, 2026 | May 26, 2026 | May 26, 2026 20:04 UTC | EDGAR |
| 8-K | 0001628280-26-027915 | Apr 28, 2026 | Apr 28, 2026 | Apr 28, 2026 20:07 UTC | EDGAR |
| 10-Q | 0001628280-26-027937 | Mar 31, 2026 | Apr 28, 2026 | Apr 28, 2026 20:15 UTC | EDGAR |
| 8-K | 0001628280-26-009018 | Feb 18, 2026 | Feb 18, 2026 | Feb 18, 2026 21:05 UTC | EDGAR |
| 10-K | 0001628280-26-005345 | Dec 31, 2025 | Feb 4, 2026 | Feb 4, 2026 17:39 UTC | EDGAR |
| 8-K | 0001628280-26-005016 | Feb 3, 2026 | Feb 3, 2026 | Feb 3, 2026 21:17 UTC | EDGAR |
| 8-K | 0001628280-26-004388 | Jan 27, 2026 | Jan 30, 2026 | Jan 30, 2026 21:08 UTC | EDGAR |
Direct links to SEC EDGAR. MDLZ has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q3 2012
Major restatementwas$788M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2010
Major restatementwas$3.6B
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2012
Major restatementwas$1.1B
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2011
Major restatementwas$4.8B
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2012
Major restatementwas$1.4B
Revised down in a 10-Q.
Operating Income (Loss)·FY 2010
Major restatementwas$5.7B
Revised down in a 10-K.
MDLZ is not the only one.
See every restatement we've found across the market — or get an alert the next time MDLZ revises a number.
Restatements are detected by comparing every vintage of a fact across all of Mondelez International, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows MDLZ's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Mondelez International, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on MDLZ yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on MDLZ and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $36.02B |
| $31.50B |
| $28.72B |
| Gross Profit | $10.94B | $14.26B | $13.76B | $11.31B | $11.25B |
|---|
| Operating Income | $3.55B | $6.34B | $5.50B | $3.53B | $4.65B |
|---|
| Net Income | $2.45B | $4.61B | $4.96B | $2.72B | $4.30B |
|---|
| EPS (Diluted) | $1.89 | $3.42 | $3.62 | $1.96 | $3.04 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $71.49B | $68.50B | $71.39B | $71.16B | $67.09B |
| Total Liabilities | $45.60B | $41.54B | $43.02B | $44.24B | $38.77B |
| Stockholders' Equity | $25.89B | $26.96B | $28.37B | $26.92B | $28.32B |
| Cash & Equivalents | $2.13B | $1.40B | $1.88B | $1.95B | $3.55B |
| Total Debt | $17.22B | $15.66B | $16.89B | $20.25B | $17.55B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.51B | $4.91B | $4.71B | $3.91B | $4.14B |
| Capital Expenditures | $1.28B | $1.39B | $1.11B | $0.91B | $0.96B |
| Free Cash Flow | $3.23B | $3.52B | $3.60B | $3.00B | $3.18B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 28.4% | 39.1% | 38.2% | 35.9% | 39.2% |
| Operating Margin | 0.1% | 0.2% | 0.2% | 0.1% | 0.2% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 9.3% | 16.7% | 17.9% | 9.8% | 15.4% |
| Return on Assets | 3.5% | 6.6% | 7.0% | 3.9% | 6.4% |
| Debt / Equity | 0.67× | 0.58× | 0.60× | 0.75× | 0.62× |
